Rebalix
Amundi · sheet of 10 September 2026
Amundi · sheet of 10 September 2026ETF sheet · official issuer and register data
Amundi IBEX 35 Doble Inverso Diario (-2x) UCITS ETF Acc
2INVE · FR0011036268 · class Acc · EUR · domicile France
Equity · Spain · Large capinverse -2xSFDR art. 6
Index tracked: IBEX 35 Double Short
- TER
- 0.60%+ trans. 0.00%
- Fund size
- 37 m EUR
- Tracking difference
- +0.06%3-year avg
- 🇮🇹 tax rate
- —white list not published
- Replication
- Synthetic (swap)
- Income
- Accumulating
Launch 19 Apr 2018 · costs from the KID as of 2 Sept 2026 · 27 securities held · 1 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 4 Aug 2026
The Sub-fund is a passively managed index-based UCITS. The Fund's objective is to be inversely exposed with a daily rebalancing to the Spanish stock market by replicating, both upwards and downwards, the performance of the Ibex 35® Doble Inverso Total Return strategy index (gross dividends reinvested) (the "Benchmark"), denominated in euro (EUR) and which is a short selling strategy (with a daily -2x leverage effect), with daily rebalancing, on the Ibex 35® index (gross dividends reinvested) (the "Parent Index"), the main Spanish stock exchange index,…
Performance since series start (in euro) — base 100
1 Oct 2012 → 8 Sept 2026 · dividends reinvested where declared by the issuer
Returns in euro
| 1 year | −48.9% |
| 3 years | −81.9% |
| 5 years | −87.8% |
| 10 years | −95.4% |
| Since series start | −98.7% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 32.16% | 30.43% | 32.56% |
| Max drawdown | −49.25% | −84.00% | −90.43% |
| Sharpe | -1.91 | -1.79 | -1.20 |
| Sortino | -2.47 | -2.42 | -1.67 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · 2INVE · FR00110362681
Rebalix2INVE · FR0011036268 · sheet of 10 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · declared by the issuer
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | −58.82% | −59.26% | +0.44% |
| 2024 | −26.92% | −27.02% | +0.10% |
| 2023 | −37.22% | −36.87% | −0.35% |
| 2022 | −7.47% | −6.73% | −0.73% |
| 2021 | −25.67% | −25.02% | −0.65% |
Holdings
Synthetic replication: top positions of the substitute basket (swap collateral), not the fund’s exposure · 1 Sept 2026 · 27 securities · top-10 weight = 56.2%
| Top holdings | Weight |
|---|---|
| 8.9% | |
| 7.3% | |
| 7.2% | |
| 6.3% | |
| 4.9% | |
| 4.4% | |
| 4.4% | |
| 4.3% | |
| 4.3% | |
| 4.3% |
Listing venues
ESMA register (FIRDS) and official exchange lists
— · BME (Bolsa de Madrid)
+ 11 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/FR0011036268
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/FR0011036268
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · 2INVE · FR00110362682